Episode

389: Hims' Super Bowl fallout, and the FDA reverses course

Podcast
The Readout Loud
Published
Feb 19, 2026
Duration seconds
2060
Processing state
not_requested
Canonical source
https://traffic.megaphone.fm/TTSAA4438066659.mp3?updated=1771534813
Audio
https://traffic.megaphone.fm/TTSAA4438066659.mp3?updated=1771534813
JSON
/v1/public/podcasts/the-readout-loud-1134305/episodes/389-hims-super-bowl-fallout-and-the-fda-reverses-course
Markdown
/podcast/the-readout-loud-1134305/389-hims-super-bowl-fallout-and-the-fda-reverses-course.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-readout-loud-1134305/episodes/389-hims-super-bowl-fallout-and-the-fda-reverses-course/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-readout-loud-1134305/389-hims-super-bowl-fallout-and-the-fda-reverses-course.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Was Hims' Super Bowl ad the final straw for regulators? Is the bar being lowered for psychedelic medicines? And what's happening behind-the-scenes with Moderna and the Food and Drug Administration? We discuss all that on this week's episode of "The Readout LOUD." STAT's Katie Palmer joins Adam, Elaine, and Allison to discuss the Hims GLP-1 pill fallout. The hosts also discuss the latest on Moderna's influenza vaccine application and Compass Pathways' depression psychedelic data.